Laurion Capital Management LP Pacira Bio Sciences, Inc. Transaction History

Laurion Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$28.4 - $50.7 $633,320 - $1.13 Million	-22,300 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$36.31 - $46.83 $809,713 - $1.04 Million	22,300 New	22,300 $1.01 Million
Q3 2019 Nov 13, 2019	SELL	$35.66 - $44.99 $463,615 - $584,914	-13,001 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$36.57 - $47.97 $1.18 Million - $1.55 Million	-32,339 Reduced 71.33%	13,001 $565,000
Q1 2019 May 08, 2019	BUY	$36.47 - $42.17 $1.65 Million - $1.91 Million	45,340 New	45,340 $1.73 Million
Q2 2018 Aug 13, 2018	SELL	$27.5 - $39.8 $2.64 Million - $3.83 Million	-96,126 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$29.98 - $46.35 $2.88 Million - $4.46 Million	96,126 New	96,126 $2.99 Million

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.